Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signaling

Abstract

BackgroundIncreasing evidence supports the association of CTNND1 with tumor development and progression. However, the mechanism and clinical significance of CTNND1 deregulation in hepatocellular carcinoma (HCC) remains unknown. In this study, we aim to investigate the role of CTNND1 in HCC.MethodsqRT-PCR and immunohistochemical analyses were used to measure the levels of CTNND1 in HCC specimens and HCC cell lines. CTNND1 and shCTNND1 were transfected into HCC cell lines to investigate its role in HCC. Cell migration and invasion were measured by Transwell and Matrigel analyses in vitro. In vivo metastasis assays were performed in SCID mice.ResultsIn clinical HCC samples, we found that CTNND1 expression was significantly up-regulated in cancer lesions compared with paired normal liver tissues. By silencing or overexpressing CTNND1 in HCC cells, we found that CTNND1 could promote cell proliferation, migration, and invasion in vitro. An in-vivo assay showed that CTNND1 dramatically promoted HCC cell tumor formation and metastasis. Moreover, CTNND1 promoted HCC metastasis, at least in part, by indirectly enhancing Wnt/β-catenin signaling. Consistent with these results, the expression of CTNND1 was positively correlated with β-catenin, WNT11, Cyclin D1, and BMP7 expression in human HCC specimens.ConclusionsOur study provides evidence that CTNND1 functions as a novel tumor oncogene in HCC, and may be a potential therapeutic target for HCC management.Electronic supplementary materialThe online version of this article (doi:10.1186/s13046-016-0344-9) contains supplementary material, which is available to authorized users.

RETRACTED ARTICLE: Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression

“…And Wnt signaling pathway has been proved to be key regulators of EMT and tumor invasion [24–26]. Therefore, we sought to investigate whether CDK16 plays a role in β-catenin signaling or not.…”

WAKMAR2, a Long Noncoding RNA Downregulated in Human Chronic Wounds, Modulates Keratinocyte Motility and Production of Inflammatory Chemokines

“…Using the STRING database, we analyzed functional protein association network among the WAKMAR2-regulated genes (Supplementary Figure S8 online) (von Mering et al, 2007). Notably, many genes in this network, in particular the centrally located nodes identified based on topologic features ( Supplementary Table S6 online), have been previously involved in regulating cell migration, for example, IRAK4 and CTNND1 (Bouma et al, 2009;Tang et al, 2016), or inflammatory response, for example, IL1B, MDM2, and IRF7 (Hauser et al, 2016;Ren and Torres, 2009;Zhao et al, 2015). Interestingly, the expression levels of 6 among the top 20 central hubs, that is, ACACA, IL1B, ACSF2, MMP3, DSG1, and CTNND1, were found significantly correlated with the expression levels of WAKMAR2 in human skin, normal wounds and VUs, supporting that WAKMAR2 regulates their expression in vivo (Figure 6fe6k).…”

Rapid proteotyping reveals cancer biology and drug response determinants in the NCI-60 cells

“…Another recurrent, negatively-weighted predictor was CTNND1, which was identified for several compounds, including bendamustine (NSC: 138783), etoposide (NSC: 141540), valrubicin (NSC: 246131), and carmustine (NSC: 409962). CTNND1 encodes delta-catenin, whose overexpression promotes cell survival through activation of Wnt pathway signaling 49 . The resulting inhibition of apoptosis 50 could plausibly confer resistance to the mentioned DNA-damage inducing drugs.…”